Green J S, Bear J C, Johnson G J
Br J Ophthalmol. 1986 Sep;70(9):696-9. doi: 10.1136/bjo.70.9.696.
We determined the underlying aetiology of blindness for the registered blind population of the Province of Newfoundland and Labrador. In both 1981 and 1984 single-gene disorders accounted for 30% of total blindness and congenital defects for another 10-11%. Genetically determined conditions, diabetes, and senile macular degeneration (SMD) were the three leading causes of registration in each year, 1980-4. We calculated mean ages of registration and mean ages of death over the last four years for five major aetiological groups. Patients with genetic conditions were registered at a much younger age and had a correspondingly longer duration of blindness (21 years as compared with 5 years for either diabetes or SMD). Total 'person-years of blindness' was then calculated from the product of this duration of blindness and the total numbers registered in each group. This index shows that the overall individual and population impact of monogenic blindness is overwhelmingly greater than that of other causes (6849 person-years compared with 270 for diabetes and 430 for SMD). In view of this frequency and duration of monogenic blindness, and also of the substantial hereditary liability to relatively common causes of blindness such as glaucoma, diabetic retinopathy, and high myopia, we suggest that more attention needs to be paid to elucidating the genetic contribution to blindness.
我们确定了纽芬兰与拉布拉多省登记在册的盲人的潜在致盲病因。在1981年和1984年,单基因疾病占失明总数的30%,先天性缺陷占另外的10% - 11%。基因决定的疾病、糖尿病和老年性黄斑变性(SMD)是1980 - 1984年每年导致登记失明的三大主要原因。我们计算了五个主要病因组在过去四年的平均登记年龄和平均死亡年龄。患有基因疾病的患者登记年龄要小得多,相应地失明持续时间更长(21年,而糖尿病或SMD患者为5年)。然后根据失明持续时间与每组登记总数的乘积计算出“失明人年数”的总数。该指数表明,单基因失明对个体和总体的影响远远大于其他病因(6849人年,而糖尿病为270人年,SMD为430人年)。鉴于单基因失明的发生频率和持续时间,以及诸如青光眼、糖尿病视网膜病变和高度近视等相对常见致盲原因的重大遗传易感性,我们建议应更加关注阐明失明的遗传因素。